Status:
COMPLETED
Eating RePace Study
Lead Sponsor:
Children's Hospital of Philadelphia
Conditions:
Obesity
Rapid Eating Style
Eligibility:
All Genders
4-7 years
Phase:
NA
Brief Summary
The aims of this study are to develop a novel family-based behavioral intervention (Re-Pace) to help children at risk for obesity (children who eat rapidly and have an overweight parent/legal guardian...
Detailed Description
Childhood obesity is one of nation's foremost public health epidemics, for which more potent and enduring prevention interventions are needed. The goal of this program of research is to study novel me...
Eligibility Criteria
Inclusion
- Children:
- Males or females 4 to 7 years of age.
- Participants (the children) have a body mass index (BMI) for age and sex between the 65th-\<96th percentile (thus, the children will not have a BMI at the 97th percentile or more).
- Parental/guardian permission (informed consent).
- Have an overweight or obese participating parent/guardian with a BMI of \> 27 kg/m2
- Increased child eating rate as reported on the questionnaire (Child Eating Behavior Questionnaire) by the parent/guardian
- Parents:
- Parent/legal guardian of subject.
- Age 21 years and above.
- Have a BMI of \> 27 kg/m2.
Exclusion
- Children:
- Children who have any developmental, medical, or psychiatric condition which might affect study compliance, as described by parental (caregiver) report.
- Children who have serious medical conditions or use of medications (e.g., chronic oral steroids, antipsychotic medications) known to affect food intake or body weight, as described by parental report.
- Children who have food allergies which may influence consumption of test foods, as reported by the parent; any child with reported peanut allergy.
- Parents/guardians or subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures.
- Parents:
- Parents/guardians who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures.
Key Trial Info
Start Date :
November 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT02186379
Start Date
November 1 2012
End Date
October 1 2014
Last Update
April 24 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104